Patents Represented by Attorney, Agent or Law Firm Richard B. Love
  • Patent number: 6197927
    Abstract: Z domain variants of staphylococcal protein A have significantly reduced size but possess IgG-binding affinity equivalent to the wild type Z domain. These Z domain variants are suitable for use in affinity chromatography purification of proteins and in the treatment of staphylococcic diseases.
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: March 6, 2001
    Assignee: Genentech Inc.
    Inventors: Andrew C. Braisted, Melissa A. Starovasnik, James A. Wells
  • Patent number: 6133426
    Abstract: Humanized anti-IL-8 monoclonal antibodies and variants thereof are described for use in diagnostic applications and in the treatment of inflammatory disorders. Also described is a conjugate formed by an antibody fragment covalently attached to a non-proteinaceous polymer, wherein the apparent size of the conjugate is at least about 500 kD. The conjugate exhibits substantially improved half-life, mean residence time, and/or clearance rate in circulation as compared to the underivatized parental antibody fragment.
    Type: Grant
    Filed: February 20, 1998
    Date of Patent: October 17, 2000
    Assignee: Genentech, Inc.
    Inventors: Tania N. Gonzalez, Steven R. Leong, Leonard G. Presta
  • Patent number: 6117980
    Abstract: Humanized anti-IL-8 monoclonal antibodies and variants thereof are described for use in diagnostic applications and in the treatment of inflammatory disorders.
    Type: Grant
    Filed: February 21, 1997
    Date of Patent: September 12, 2000
    Assignee: Genentech, Inc.
    Inventors: Tania N. Gonzalez, Steven R. Leong, Leonard G. Presta
  • Patent number: 6087475
    Abstract: cDNAs encoding a class of receptors, including the IL-8 receptors, have been identified in human tissue. Recombinantly produced PF4ARs are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. The antibodies are advantageously used in the prevention and treatment of inflammatory conditions.
    Type: Grant
    Filed: June 24, 1998
    Date of Patent: July 11, 2000
    Assignee: Genentech, Inc.
    Inventors: James Lee, William I. Wood
  • Patent number: 6025158
    Abstract: Humanized anti-IL-8 monoclonal antibodies and variants thereof are described for use in diagnostic applications and in the treatment of inflammatory disorders. Also described is a conjugate formed by an antibody fragment covalently attached to a non-proteinaceous polymer, wherein the apparent size of the conjugate is at least about 500 kD. The conjugate exhibits substantially improved half-life, mean residence time, and/or clearance rate in circulation as compared to the underivatized parental antibody fragment.
    Type: Grant
    Filed: February 20, 1998
    Date of Patent: February 15, 2000
    Assignee: Genentech, Inc.
    Inventors: Tania N. Gonzalez, Steven R. Leong, Leonard G. Presta
  • Patent number: 6013763
    Abstract: Z domain variants of staphylococcal protein A have significantly reduced size but possess IgG-binding affinity equivalent to the wild type Z domain. These Z domain variants are suitable for use in affinity chromatography purification of proteins and in the treatment of staphylococcic diseases.
    Type: Grant
    Filed: June 4, 1996
    Date of Patent: January 11, 2000
    Assignee: Genentech, Inc.
    Inventors: Andrew C. Braisted, Melissa A. Starovasnik, James A. Wells
  • Patent number: 5968767
    Abstract: A method is provided for in vitro protein synthesis in a bacterial extract wherein the reaction mixture comprises a reducing agent and dissolved oxygen (DO.sub.2) wherein the DO.sub.2 concentration is regulated such that complete oxidation of the reducing agent concentration does not occur for a period of at least about 30 minutes following initiation of protein synthesis in the reaction mixture. Also provided is a method for in vitro protein synthesis in bacterial extracts wherein the reaction mixture comprises an initial methionine concentration of at least about 1.0 mM, or wherein the reaction mixture comprises both labeled and unlabeled methionine, and the initial concentration of unlabeled methionine is at least about 0.1 mM.
    Type: Grant
    Filed: June 5, 1997
    Date of Patent: October 19, 1999
    Assignee: Genentech, Inc.
    Inventors: Amina Sheikh, James R. Swartz
  • Patent number: 5922541
    Abstract: cDNAs encoding a class of receptors, including the IL-8 receptors, have been identified in human tissue. Recombinantly produced PF4ARs are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. The antibodies are advantageously used in the prevention and treatment of inflammatory conditions. The cDNAs are also used to detect nucleic acids in samples. The cDNAs are also used to detect nucleic acids in samples.
    Type: Grant
    Filed: February 19, 1997
    Date of Patent: July 13, 1999
    Assignee: Genentech, Inc.
    Inventors: James Lee, William I. Wood
  • Patent number: 5919896
    Abstract: cDNAs encoding a class of receptors, including the IL-8 receptors, have been identified in human tissue. Recombinantly produced PF4ARs are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. The antibodies are advantageously used in the prevention and treatment of inflammatory conditions.
    Type: Grant
    Filed: February 19, 1997
    Date of Patent: July 6, 1999
    Assignee: Genentech, Inc.
    Inventors: James Lee, William I. Wood
  • Patent number: 5892017
    Abstract: cDNAs encoding a class of receptors, including the IL-8 receptors, have been identified in human tissue. Recombinantly produced PF4ARs are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. The antibodies are advantageously used in the prevention and treatment of inflammatory conditions.
    Type: Grant
    Filed: February 19, 1997
    Date of Patent: April 6, 1999
    Assignee: Genentech, Inc.
    Inventors: James Lee, William I. Wood
  • Patent number: 5874080
    Abstract: Methods are provided for the treatment of asthma with anti-IL-8 monoclonal antibodies.
    Type: Grant
    Filed: June 27, 1995
    Date of Patent: February 23, 1999
    Assignee: Genentech, Inc.
    Inventors: Caroline A. Hebert, Rhona C. Kabakoff, Mark W. Moore
  • Patent number: 5874543
    Abstract: cDNAs encoding a class of receptors, including the IL-8 receptors, have been identified in human tissue. Recombinantly produced PF4ARs are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. The antibodies are advantageously used in the prevention and treatment of inflammatory conditions.
    Type: Grant
    Filed: February 25, 1997
    Date of Patent: February 23, 1999
    Assignee: Genetech, Inc.
    Inventors: Anan Chuntharapai, James Lee, Caroline Hebert, K. Jin Kim
  • Patent number: 5856457
    Abstract: The cDNA encoding a member of or a class of novel PF4A receptors has been identified in human tissue. Provided herein is nucleic acid sequence of a PF4A receptor (the IL-8 receptor) useful as a diagnostic and in the recombinant preparation of PF4A receptors. The PF4A receptor is used in the preparation and purification of antibodies capable of binding to the receptor, and in diagnostic assays.
    Type: Grant
    Filed: March 24, 1995
    Date of Patent: January 5, 1999
    Assignee: Genentech, Inc.
    Inventors: James Lee, William E. Holmes, William I. Wood
  • Patent number: 5840844
    Abstract: DNA isolates coding for the lymphocyte homing receptor and methods of obtaining such DNA are provided, together with expression systems for recombinant production of the lymphocyte homing receptor useful in therapeutic or diagnostic compositions.
    Type: Grant
    Filed: August 10, 1995
    Date of Patent: November 24, 1998
    Assignee: Genentech, Inc. University of California
    Inventors: Laurence A. Lasky, Steven D. Rosen, Scott E. Stachel, Mark S. Singer
  • Patent number: 5840856
    Abstract: cDNAs encoding a class of receptors, including the IL-8 receptors, have been identified in human tissue Recombinantly produced PF4ARs are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. The antibodies are advantageously used in the prevention and treatment of inflammatory conditions.
    Type: Grant
    Filed: August 10, 1994
    Date of Patent: November 24, 1998
    Assignee: Genentech, Inc.
    Inventors: Anan Chuntharapai, James Lee, Caroline Hebert, K. Jin Kim
  • Patent number: 5831023
    Abstract: Distinct .alpha.-, .beta.- and .gamma.-interferon genes from various animal species have been identified, cloned and expressed to produce the corresponding non-human animal interferon proteins. Specifically disclosed are interferons of bovine, porcine, feline and rabbit origin.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: November 3, 1998
    Assignee: Genentech, Inc.
    Inventors: Daniel J. Capon, David V. Goeddel
  • Patent number: 5827694
    Abstract: Distinct .alpha.-, .beta.- and .gamma.-interferon genes from various animal species have been identified, cloned and expressed to produce the corresponding non-human animal interferon proteins. Specifically disclosed are interferons of bovine, porcine, feline and rabbit origin.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: October 27, 1998
    Assignee: Genentech, Inc.
    Inventors: Daniel J. Capon, David V. Goeddel
  • Patent number: 5783415
    Abstract: The cDNA encoding a member of or a class of novel PF4A receptors has been identified in human tissue. Provided herein is nucleic acid sequence of a PF4A receptor (the IL-8 receptor) useful as a diagnostic and in the recombinant preparation of PF4A receptors. The PF4A receptor is used in the preparation and purification of antibodies capable of binding to the receptor, and in diagnostic assays.
    Type: Grant
    Filed: March 24, 1995
    Date of Patent: July 21, 1998
    Assignee: Genentech, Inc.
    Inventors: James Lee, William E. Holmes, William I. Wood
  • Patent number: 5776457
    Abstract: cDNAs encoding a class of receptors, including the IL-8 receptors, have been identified in human tissue. Recombinantly produced PF4ARs are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. The antibodies are advantageously used in the prevention and treatment of inflammatory conditions.
    Type: Grant
    Filed: August 22, 1996
    Date of Patent: July 7, 1998
    Assignee: Genentech, Inc.
    Inventors: James Lee, William I. Wood
  • Patent number: 5767063
    Abstract: The cDNA encoding a member of or a class of novel PF4A receptors has been identified in human tissue. Provided herein is nucleic acid sequence of a PF4A receptor (the IL-8 receptor) useful as a diagnostic and in the recombinant preparation of PF4A receptors. The PF4A receptor is used in the preparation and purification of antibodies capable of binding to the receptor, and in diagnostic assays.
    Type: Grant
    Filed: March 24, 1995
    Date of Patent: June 16, 1998
    Assignee: Genentech, Inc.
    Inventors: James Lee, William E. Holmes, William I. Wood